Neuroscience and Behavioral Physiology

, Volume 40, Issue 7, pp 807–811 | Cite as

Interaction of Blockers of Ionotropic NMDA Receptors and Metabotropic Glutamate Receptors in a Working Memory Test in Rats

  • Y. A. Novitskaya
  • O. A. Dravolina
  • E. E. Zvartau
  • W. Danysz
  • A. Y. Bespalov

Glutamate, the main excitatory neurotransmitter in the mammalian CNS, acts via ionotropic and metabotropic receptors. Results from in vitro studies demonstrating tight interactions between ionotropic NMDA receptors and subtype 5 metabotropic glutamate receptors (mGlu5) have shown that blockade of mGlu5 receptors increases the behavioral effects of NMDA receptor antagonists. The aim of the present work was to study the actions of the highly selective mGlu5 receptor antagonist MTEP alone and in combination with MK-801, a blocker of the NMDA receptor-associated ion channel, on performance of a delayed selection task (a test of working memory) in rats. MK-801 (0.1 mg/kg) induced a specific impairment to working memory, with proactive interference (degradation of the ability to remember current information because of the effects of previously learned material). Administration of MTEP (5.0 mg/kg) combined with both solvent and with MK-801 had no significant effects, demonstrating the small or nonexistent involvement of mGlu5 receptors in the mechanisms of working memory.

Key words

schizophrenia working memory proactive interference NMDA receptors MK-801 metabotropic glutamate receptors MTEP rats 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    J. J. Anderson, S. P. Rao, B. Rowe, D. R. Giracello, G. Holtz, D. F. Chapman, L. Tehrani, M. J. Bradbury, N. D. Cosford, and M. A. Varney, “[3H]Methoxymethyl-3-[(2-methyl-1,3-thiazol-4-yl)ethynyl] pyridine binding to metabotropic glutamate receptor subtype 5 in rodent brain: in vitro and in vivo characterization,” J. Pharmacol. Exp. Ther., 303, 1044-1051 (2002).CrossRefPubMedGoogle Scholar
  2. 2.
    U. C. Campbell, K. Lalwani, L. Hernandez, G. G. Kinney, P. J. Conn, and L. J. Bristow, “The mGluR5 antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP) potentiates PCP-induced cognitive deficits in rats,” Psychopharmacology, 175, 310–318 (2004).CrossRefPubMedGoogle Scholar
  3. 3.
    P. J. Conn and J. P. Pin, “Pharmacology and functions of metabotropic glutamate receptors,” Ann. Rev. Pharmacol. Toxicol., 37, 205–237 (1997).CrossRefGoogle Scholar
  4. 4.
    N. D. Cosford, J. Roppe, L. Tehrani, E. J. Schweiger, T. J. Seiders, A. Chaudary, S. Rao, and M. A. Varney, “[3H]-methoxymethyl-MTEP and [3H]-methoxy-PEPy: potent and selective radioligands for the metabotropic glutamate subtype 5 (mGlu5) receptor,” Med. Chem. Lett., 13, 351–354 (2003).CrossRefGoogle Scholar
  5. 5.
    N. D. Cosford , L. Tehrani, J. Roppe, E. Schweiger, N. D. Smith, J. Anderson, L. Bristow, J. Brodkin, X. Jiang, I. McDonald, S. Rao, M. Washburn, and M. A. Varney, “3-[(2-Methyl-l,3-thiazol-4-yl)ethynyl]-pyridine: a potent and highly selective metabotropic glutamate subtype 5 receptor antagonist with anxiolytic activity,” J. Med. Chem., 46, 204–206 (2003).CrossRefPubMedGoogle Scholar
  6. 6.
    R. Dingledine, K. Borges, D. Bowie, and S. F. Traynelis, “The glutamate receptor ion channels,” Pharmacol. Rev., 51, 7–61 (1999).PubMedGoogle Scholar
  7. 7.
    S. B. Dunnett and F. L. Martel, “Proactive interference effects on short-term memory in rats: I. Basic parameters and drug effects,” Behav. Neurosci., 104, No. 5, 655–665 (1990).CrossRefPubMedGoogle Scholar
  8. 8.
    S. M. Fitzjohn, A. J. Irving, M. J. Palmer, J. Harvey, D. Lodge, and G. L. Collingridge, “Activation of group I mGluRs potentiates NMDA responses in rat hippocampal slices,” Neurosci. Lett., 203, No. 26, 211–213 (1996).CrossRefPubMedGoogle Scholar
  9. 9.
    C. A. Heidbreder, M. Bianchi, L. P. Lacroix, S. Faedo, E. Perdona, R. Remelli, P. Cavanni, and F. Crespi, “Evidence that the metabotropic glutamate receptor 5 antagonist MPEP may act as an inhibitor of the norepinephrine transporter in vitro and in vivo,” Synapse, 50, 269–276 (2003).CrossRefPubMedGoogle Scholar
  10. 10.
    S. A. Henry, V. Lehmann-Masten, F. Gasparini, M. A. Geyer, and A. Marcou, “The mGluRS antagonist MPEP, but not the mGluR2/3 agonist LY314582, augments PCP effects on prepulse inhibition and locomotor activity,” Neuropharmacology, 43, 1199–1209 (2002).CrossRefPubMedGoogle Scholar
  11. 11.
    H. Homayoun, M. R. Stefani, B. W. Adams, G. D. Tamagen, and B. Moghaddam, “Functional interaction between NMDA and mGlu5 receptors: effects on working memory, instrumental learning, motor behaviors, and dopamine release,” Neuropharmacology, 29, 1259–1269 (2004).Google Scholar
  12. 12.
    P. M. Lea and A. I. Faden, “Metabotropic glutamate receptor subtype 5 antagonists MPEP and MTEP,” CNS Drugs Revs., 12, No. 2, 149–166 (2006).CrossRefGoogle Scholar
  13. 13.
    T. Makovski and Y. V. Jiang, “Proactive interference from items previously stored in visual working memory,” Mem. Cognit., 36, No. 1, 43–52 (2008).CrossRefPubMedGoogle Scholar
  14. 14.
    Y. Novitskaya and A. Y. Bespalov, “Proactive interference induced by NMDA receptor channel blockade in working memory task in rats,” Psychopharmacology (2009).Google Scholar
  15. 15.
    D. M. O’Leary, M. Movsesyan, S. Vicini, and A. I. Faden, “Selective mGluR5 antagonists MPEP and SIB-1893 decrease NMDA or glutamate-mediated neuronal toxicity through actions that reflect NMDA receptor antagonism,” Brit. J. Pharmacol., 131, 1429–1437 (2000).CrossRefGoogle Scholar
  16. 16.
    S. Park and P. S. Holzman, “Schizophrenics show spatial working memory deficits,” Arch. Gen. Psychiatry, 49, 975–982 (1992).PubMedGoogle Scholar
  17. 17.
    M. Pietraszek, A. Gravius, D. Schäfer, T. Weil, D. Trifanova, and W. Danysz, “mGluRS, but not mGluRl, antagonist modifies MK-801-induced locomotor activity and deficit of prepulse inhibition,” Neuropharmacology, 49, No. 1, 73085 (2005).CrossRefGoogle Scholar
  18. 18.
    S. Sahai, “Glutamate in the mammalian CNS,” CNS Eur. Arch. Psychiatry Clin. Neurosci., 240, No. 2, 121–133 (1990).CrossRefGoogle Scholar
  19. 19.
    R. Shigemoto, S. Nomura, H. Ohishi, H. Sugihara, S. Nakanishi, and N. Mizumo, “Immunohistochemical localization of a metabotropic glutamate receptor, mGluR5, in the rat brain,” Neurosci. Lett., 26, No. 163, 53–57 (1993).CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, Inc. 2010

Authors and Affiliations

  • Y. A. Novitskaya
    • 1
  • O. A. Dravolina
    • 1
  • E. E. Zvartau
    • 1
  • W. Danysz
    • 2
  • A. Y. Bespalov
    • 3
  1. 1.Department of Psychopharmacology, Valdman Institute of PharmacologyPavlov St. Petersburg State Medical UniversitySt. PetersburgRussia
  2. 2.Department of NeurosciencesAbbottLudwigshafenGermany
  3. 3.Department of Preclinical StudiesMerz PharmaceuticalsFrankfurt-am-MainGermany

Personalised recommendations